Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
05/2012
05/24/2012WO2012067262A1 Therapeutic agent for muscular dystrophy
05/24/2012WO2011153277A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
05/24/2012WO2011152618A3 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof
05/24/2012US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics
05/24/2012US20120129920 miR-31 IN DUCHENNE MUSCULAR DYSTROPHY THERAPY
05/24/2012US20120129828 S1p1 receptor agonists and use thereof
05/24/2012US20120129776 Bioactive peptides and method of using same
05/24/2012US20120129758 Muscle function enhancing peptide
05/24/2012US20120128771 Timed, pulsatile release systems
05/24/2012US20120128737 Compositions for treating degenerative joint diseases
05/24/2012US20120128649 Modified non-cytotoxic proteases
05/23/2012EP2454265A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
05/23/2012EP2453893A1 Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers
05/23/2012CN1659288B Pharmaceutical composition for preventing or reducing DNA damage
05/23/2012CN102470169A Autoantibody production inhibitor
05/23/2012CN102462685A 一种咪达唑仑组合物、其制备方法及用途 One kind of midazolam compositions, their preparation and use
05/23/2012CN102462672A 一种雷莫司琼透皮贴剂及其制备方法 Ramosetron transdermal patch and its preparation method
05/23/2012CN102125612B Chinese medicinal preparation for treating acute lumbar sprain
05/23/2012CN102048852B Oral medicament for treating cerebral infarction and relieving limb spasm
05/23/2012CN102000275B Medicinal composition for treating children with tic disorders and preparation method thereof
05/23/2012CN101530620B Triphosadenine intercalated houghite membrane and preparation method thereof
05/22/2012US8183295 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
05/22/2012US8183222 Method to inhibit cell growth using oligonucleotides
05/18/2012WO2012064090A2 Chemical preparation method of skeletal muscle-derived multipotent cells and use thereof
05/17/2012US20120122982 Use of pufas to treat nerve damage
05/17/2012US20120122953 Methods for enhancing utrophin production via inhibition of microrna
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122836 Polymorphic form of 1-(4--2-ethyl-benzyl)-azetidine-3-carboxylic
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122801 Mannose-6-phosphate receptor mediated gene transfer into muscle cells
05/17/2012US20120122778 Modified TGF-beta superfamily protein
05/17/2012US20120121675 Compounds which inhibit muscle contraction
05/17/2012US20120121602 Novel proteins
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121583 Antibodies against human tweak and uses thereof
05/17/2012US20120121556 Methods of using regenerative cells to promote wound healing
05/16/2012EP2453009A1 Methods of organ regeneration
05/16/2012CN102459576A Compositions and methods for modulating stem cells and uses thereof
05/16/2012CN102459221A 噻吩衍生物 Thiophene derivative
05/16/2012CN102458579A 吡嗪并氧氮杂*衍生物 Pyrazino oxazepin * Derivatives
05/16/2012CN102458428A Nfat signal inhibitor and calcineurin inhibitor
05/16/2012CN101897766B Anti-inflammatory and analgesic medicine composition as well as preparation method and application thereof
05/15/2012US8178518 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders
05/15/2012CA2517893C Use as medications of cholest-4-en-3-one derivatives, pharmaceutical compounds containing them, new derivatives and their preparation process
05/15/2012CA2448933C A retinoic acid metabolizing cytochrome p450
05/15/2012CA2378243C Methods for treating or preventing pain and anxiety
05/10/2012US20120115886 Fused pyrimidineone compounds as trpv3 modulators
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115845 Therapeutic agents
05/10/2012US20120115840 Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acid
05/10/2012US20120115824 Vitamin D Receptor Agonists and Uses Thereof
05/10/2012US20120115803 Treatment of acinetobacter with alginate oligomers and antibiotics
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120114743 Transdermal ricinoleic acid compositions
05/10/2012US20120114741 Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114594 Muscle repair promoter
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/09/2012EP2448971A1 Methods for treatment of muscular dystrophy
05/09/2012EP1423107B1 Fatty alcohol drug conjugates
05/09/2012CN102448949A Heterocyclic compound and hematopoietic stem cell amplifier
05/09/2012CN102448937A Aryl Substituted Carboxamide Derivatives As Calcium Or Sodium Channel Blockers
05/09/2012CN102448930A Thiocolchicine derivatives, method of making and methods of use thereof
05/09/2012CN102442918A Stable levocarnitine compound
05/09/2012CN102441087A Traditional Chinese medicine for treating gout and twitch and preparation method thereof
05/09/2012CN102441060A Traditional Chinese medicine preparation for treating progressive muscular atrophy symptom
05/09/2012CN102440973A Diphenhydramine citrate orally disintegrating tablet and preparation method thereof
05/08/2012US8173779 Neutralizing human anti-IGFR antibody
05/08/2012US8173138 Stable liquid formulations of botulinum toxin
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173107 Delivery of antipsychotics through an inhalation route
05/08/2012CA2368184C Method and means for treating post-polio syndrome
05/03/2012WO2012058220A2 Anti-sod1 antibodies and uses thereof
05/03/2012WO2012019002A3 Somatic stem cells
05/03/2012WO2012011673A3 Pharmaceutical composition including hesperetin as an active ingredient for promoting muscle cell differentiation or renewal
05/03/2012US20120108653 Oligomers
05/03/2012US20120108652 Oligomers
05/03/2012US20120108643 Method of increasing the extent of absorption of tizanidine
05/03/2012US20120108614 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108613 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108587 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
05/03/2012US20120108548 Molecular tweezers for the treatment of amyloid-related diseases
05/03/2012US20120107928 Antibody Inhibitors of GDF-8 and Uses Thereof
05/03/2012US20120107365 Films and particles
05/03/2012US20120107361 Albumin-Free Botulinum Toxin Formulations
05/03/2012US20120107284 Stem cells for transplantation and methods for production thereof
05/03/2012CA2819117A1 Anti-sod1 antibodies and uses thereof
05/03/2012CA2815542A1 Use of a spironolactone-based composition that exhibits an inhibitory action on t-lymphocyte activation which is useful for preventing and/or treating multiple sclerosis
05/02/2012EP2446902A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446901A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446900A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446886A1 Autophagy regulators and the uses thereof in the treatment of collagen VI defective Muscular Dystrophies
05/02/2012EP2445521A2 Albumin-free botulinum toxin formulations
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 233